Caribou Biosciences, Inc. (CRBU)

NASDAQ: CRBU · IEX Real-Time Price · USD

3.770

+0.130 (3.57%)

At close: May 3, 2024, 4:00 PM

3.700

-0.070 (-1.86%)

After-hours: May 3, 2024, 7:09 PM EDT

Caribou Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-102.07	-99.42	-66.92	-34.31	-23.43
Depreciation & Amortization	5.57	3.64	0.98	0.9	0.75
Share-Based Compensation	13.75	11.72	3.45	1	1.23
Other Operating Activities	-10.54	-6.9	29.97	-0.81	-10.56
Operating Cash Flow	-93.29	-90.97	-32.52	-33.22	-32.01
Capital Expenditures	-11.61	-6.45	-2.12	-0.31	-0.88
Acquisitions	0	-0.6	-1	-1	0
Change in Investments	-56.57	-86.2	-173.28	7.67	28.12
Investing Cash Flow	-68.18	-93.25	-176.4	6.36	27.23
Share Issuance / Repurchase	154.3	2.13	323.57	0.27	0.22
Debt Issued / Paid	0	0	1.03	1.47	-0.05
Other Financing Activities	-	-	108.83	-	-
Financing Cash Flow	154.3	2.13	433.43	1.74	0.17
Net Cash Flow	-7.18	-182.08	224.51	-25.12	-4.6
Free Cash Flow	-104.9	-97.42	-34.64	-33.52	-32.89
Free Cash Flow Margin	-304.27%	-703.34%	-360.91%	-271.19%	-568.24%
Free Cash Flow Per Share	-1.42	-1.60	-1.09	-3.92	-3.93

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).